An Investigation into the Critical Factors of on-site Waste Segregation in the UK Construction and Demolition Sector.

This paper provides an in-depth exploration into critical factors affecting the use of on-site waste segregation strategies in the UK C&D market. Utilising data from two separate survey questionnaires; this study confirms usage of on-site segregation strategies by many UK contractors where physical site space and project budgets allow. However, through assessment of stakeholder perceptions, this paper also identifies several key barriers that are impeding overall effectiveness. Amongst many factors, this study indicates how issues such as poor attitude and a lack of knowledge of the benefits amongst workers, could be having a profound effect on successful adaptation of ground level recycling initiatives. This research project then finishes by ranking existent barriers by importance, with the goal of suggesting proposals for overcoming these challenges. Ultimately, weighing the critical factors and prospective barriers to on-site segregation in the UK C&D sector, this study makes recommendation of multiple incentives, but suggests that enhanced training initiatives could be a crucial element for instigating long-term industry improvement in respect of recycling and on-site waste segregation strategies

The New Digital-Receiver-Based System for Antiproton Beam Diagnostics

An innovative system to measure antiproton beam intensity, momentum spread and mean momentum in CERN's Antiproton Decelerator (AD) is described. This system is based on a state-of-the-art Digital Receiver (DRX) board, consisting of 8 Digital Down-Converter (DDC) chips and one Digital Signal Processor (DSP). An ultra-low-noise, wide-band AC beam transformer (0.2 MHz - 30 MHz) is used to measure AC beam current modulation. For bunched beams, the intensity is obtained by measuring the amplitude of the fundamental and second RF Fourier components. On the magnetic plateaus the beam is debunched for stochastic or electron cooling and longitudinal beam properties (intensity, momentum spread and mean momentum) are measured by FFT-based spectral analysis of Schottky signals. The system thus provides real time information characterising the machine performance; it has been used for troubleshooting and to fine-tune the AD, thus achieving further improved performances. This system has been operating since May 2000 and typical results are presented

Antiproton beam parameters measurement by a new digital-receiver-based system

The Antiproton Decelerator (AD) provides the users with very low intensity beams, in the 107 particles range, hence prompting the development of an innovative measuring system, which was completed in early 2000. This system measures antiproton beam intensity for bunched and debunched beams, together with momentum spread and mean momentum for debunched beams. It uses a state-of-the-art Digital Receiver board, which processes data obtained from two ultra-low-noise, wide-band AC beam transformers. These have a combined bandwidth in the range 0.02 MHz - 30 MHz and are used to measure AC beam current modulation. For bunched beams, the intensity is obtained by measuring the amplitude of the fundamental and second RF Fourier components. On the magnetic plateaus the beam is debunched for stochastic or electron cooling and longitudinal beam properties (intensity, momentum spread and mean momentum) are measured by FFT-based spectral analysis of Schottky signals. The system provides real-time information characterising the machine performance; it has been used for troubleshooting and to fine-tune the AD, thus allowing further improved performance. This system has been operating since May 2000 and providing beam intensity data to the users on a routine basis since late 2000. A dedicated software package was expressly developed to take care of the control, data acquisition and processing phases. It consists of three main codes, namely a GUI, a Real Time Task and a Low Level Code. This report gives an overview of both the hardware and software developed

Association study of two interleukin-1 gene loci with essential hypertension in a Pakistani Pathan population

An association study of IL-1 beta -511C/T and IL-1 RN 86 bp VNTR polymorphisms with essential hypertension was carried out in a sample population of 500 Pakistani Pathan subjects selected randomly, comprising groups of 235 subjects with hypertension and 265 controls. The distribution of both genotypes and alleles was not statistically different in cases and controls. In conclusion, IL-1 beta -511C/T and IL-1 RN 86 bp VNTR do not contribute to the aetiology of essential hypertension in the Pakistani Pathan population investigated here

Beam Measurement Systems for the CERN Antiproton Decelerator (AD)

The new, low-energy antiproton physics facility at CERN has been successfully commissioned and has been delivering decelerated antiprotons at 100 MeV/c since July 2000. The AD consists of one ring where the 3.5 GeV/c antiprotons produced from a production target are injected, rf manipulated, stochastically cooled, decelerated (with further stages involving additional stochastic and electron cooling and rf manipulation) and extracted at 100 MeV/c. While proton test beams of sufficient intensity could be used for certain procedures in AD commissioning, this was not possible for setting-up and routine operation. Hence, special diagnostics systems had to be developed to obtain the beam and accelerator characteristics using the weak antiproton beams of a few 10E7 particles at all momenta from 3.5 GeV/c down to 100 MeV/c. These include systems for position measurement, intensity, beam size measurements using transverse aperture limiters and scintillators and Schottky-based tools. This paper gives an overall view of these systems and their usage

Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project

Background: Evidence of HIV drug resistance (HIVDR) in individuals using oral pre-exposure prophylaxis (PrEP) who acquire HIV is limited to clinical trials and case studies. More data are needed to understand the risk of HIVDR with oral PrEP during PrEP rollout. Mechanisms to collect these data vary, and are dependent on cost, scale of PrEP distribution, and in-country infrastructure for the identification, collection, and testing of samples from PrEP seroconverters. / Methods: The Global Evaluation of Microbicide Sensitivity (GEMS) project, in collaboration with country stakeholders, initiated HIVDR monitoring among new HIV seroconverters with prior PrEP use in Eswatini, Kenya, South Africa, and Zimbabwe. Standalone protocols were developed to assess HIVDR among a national sample of PrEP users. In addition, HIVDR testing was incorporated into existing demonstration projects for key populations. / Lessons learned: Countries are supportive of conducting a timelimited evaluation of HIVDR during the early stages of PrEP rollout. As PrEP rollout expands, the need for long-term HIVDR monitoring with PrEP will need to be balanced with maintaining national HIV drug resistance surveillance for pretreatment and acquired drug resistance. Laboratory capacity is a common obstacle to setting up a monitoring system. / Conclusions: Establishing HIV resistance monitoring within PrEP programs is feasible. Approaches to drug resistance monitoring may evolve as the PrEP programs mature and expand. The methods and implementation support offered by GEMS assisted countries in developing methods to monitor for drug resistance that best fit their PrEP program needs and resources

HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics?

<p>Abstract</p> <p>Background</p> <p>The HIV pandemic disseminated globally from Central West Africa, beginning in the second half of the twentieth century. To elucidate the virologic origins of the pandemic, a cross-sectional study was conducted of the genetic diversity of HIV-1 strains in villagers in 14 remote locations in Cameroon and in hospitalized and STI patients. DNA extracted from PBMC was PCR amplified from HIV(+) subjects. Partial <it>pol </it>amplicons (N = 164) and nearly full virus genomes (N = 78) were sequenced. Among the 3956 rural villagers studied, the prevalence of HIV infection was 4.9%; among the hospitalized and clinic patients, it was 8.6%.</p> <p>Results</p> <p>Virus genotypes fell into two distinctive groups. A majority of the genotyped strains (109/164) were the circulating recombinant form (CRF) known to be endemic in West Africa and Central West Africa, CRF02_AG. The second most common genetic form (9/164) was the recently described CRF22_01A1, and the rest were a collection of 4 different subtypes (A2, D, F2, G) and 6 different CRFs (-01, -11, -13, -18, -25, -37). Remarkably, 10.4% of HIV-1 genomes detected (17/164) were heretofore undescribed unique recombinant forms (URF) present in only a single person. Nearly full genome sequencing was completed for 78 of the viruses of interest. HIV genetic diversity was commonplace in rural villages: 12 villages each had at least one newly detected URF, and 9 villages had two or more.</p> <p>Conclusions</p> <p>These results show that while CRF02_AG dominated the HIV strains in the rural villages, the remainder of the viruses had tremendous genetic diversity. Between the trans-species transmission of SIV_cpzand the dispersal of pandemic HIV-1, there was a time when we hypothesize that nascent HIV-1 was spreading, but only to a limited extent, recombining with other local HIV-1, creating a large variety of recombinants. When one of those recombinants began to spread widely (i.e. became epidemic), it was recognized as a subtype. We hypothesize that the viruses in these remote Cameroon villages may represent that pre-epidemic stage of viral evolution.</p

Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep Pyrosequencing

Understanding the evolution of the human immunodeficiency virus type 1 (HIV-1) envelope during disease progression can provide tremendous insights for vaccine development, and simian-human immunodeficiency virus (SHIV) infection of non-human primate provides an ideal platform for such studies. A newly developed clade C SHIV, SHIV-1157ipd3N4, which was able to infect rhesus macaques, closely resembled primary HIV-1 in transmission and pathogenesis, was used to infect several pig-tailed macaques. One of the infected animals subsequently progressed to AIDS, whereas one remained a non-progressor. The viral envelope evolution in the infected animals during disease progression was analyzed by a bioinformatics approach using ultra-deep pyrosequencing. Our results showed substantial envelope variations emerging in the progressor animal after the onset of AIDS. These envelope variations impacted the length of the variable loops and charges of different envelope regions. Additionally, multiple mutations were located at the CD4 and CCR5 binding sites, potentially affecting receptor binding affinity, viral fitness and they might be selected at late stages of disease. More importantly, these envelope mutations are not random since they had repeatedly been observed in a rhesus macaque and a human infant infected by either SHIV or HIV-1, respectively, carrying the parental envelope of the infectious molecular clone SHIV-1157ipd3N4. Moreover, similar mutations were also observed from other studies on different clades of envelopes regardless of the host species. These recurring mutations in different envelopes suggest that there may be a common evolutionary pattern and selection pathway for the HIV-1 envelope during disease progression